Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Libby Watch

Vascular Surgery Miami, FL Medical Doctor

NPI 1831238864 CMS profile 37433

8950 N Kendall Dr, 504, Miami, FL 33176

Open in the dashboard

General payments

$9,754

110 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Libby Watch of Miami, FL is reported in the CMS Open Payments database as having received $9,754 across 110 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $404 11
2023 General $809 19
2022 General $3,400 25
2021 General $1,212 21
2020 General $2,416 8
2019 General $1,513 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Libby Watch
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Libby Watch were reported at $0. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Libby Watch Vascular Surgery median Middle half National median
2019 $1,513 $796 $226–$2,363 $163
2020 $2,416 $348 $118–$1,110 $114
2021 $1,212 $471 $158–$1,421 $132
2022 $3,400 $725 $222–$2,183 $149
2023 $809 $836 $257–$2,440 $160
2024 $404 $909 $252–$2,619 $164
2025 $0 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Silk Road Medical, Inc. $3,679 13 payments
  2. Bard Peripheral Vascular, Inc. $2,870 13 payments
  3. Smith+Nephew, Inc. $785 27 payments
  4. W. L. Gore & Associates, Inc. $512 8 payments
  5. Cook Medical LLC $327 3 payments
  6. Endologix, Inc. $200 2 payments
  7. Medtronic, Inc. $182 3 payments
  8. Maquet Cardiovascular U.S. Sales, L.L.C. $150 4 payments
  9. AngioDynamics, Inc. $142 1 payment
  10. Janssen Pharmaceuticals, Inc $106 6 payments
  11. Other $801 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $4,800 3 payments
  2. Food and Beverage $4,339 103 payments
  3. Travel and Lodging $615 4 payments
Products named General payments · program years 2019–2024
  1. ENROUTE Transcarotid Stent $2,880 7 payments
  2. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $2,880 7 payments
  3. ENROUTE 0.014 Guidewire $798 6 payments
  4. ENROUTE Transcarotid Stent System $798 6 payments
  5. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $798 6 payments
  6. ENHANCE Transcarotid Peripheral Access Kit Carotid Artery Disease $798 6 payments
  7. ENHANCE Transcarotid Peripheral Access Kit Cardiology/Vascular Diseases $600 1 payment
  8. ENROUTE .014 Guidewire $600 1 payment
  9. GRAFIX PL $574 14 payments
  10. Venclose Maven Catheter $426 6 payments
  11. Other $4,352 120 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$16,938

Medicare's payments for the services billed

Medicare patients

165

Average age 73

Services billed

207

84 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 59%
Arthritis 59%
Ischemic heart disease 58%
Diabetes 51%
Depression 42%
Heart failure 41%
Atrial fibrillation 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DefenCath
  • CorMedix Inc. $28
$28 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record